Literature DB >> 30883256

Implementing an Electronic End-of-Life Chemotherapy Utilization Measure.

Joshua Kraut1, Kathi Mooney2, John W Sweetenham3, Ray D Page4, Kerin Adelson5, Vineeta Agarwala1,6, Kristen L Fessele1,7, H James Hamrick1, Irene Kaganman1, James Martineau1, Amy P Abernethy1, Neal J Meropol1.   

Abstract

Mesh：

Substances：

Year:  2019        PMID： 30883256     DOI： 10.1200/JOP.18.00408

Source DB:  PubMed          Journal:  J Oncol Pract        ISSN： 1554-7477            Impact factor:   3.840


× No keyword cloud information.
  2 in total

1.  Adoption of Immune Checkpoint Inhibitors and Patterns of Care at the End of Life.

Authors:  Fauzia Riaz; Geliang Gan; Fangyong Li; Amy J Davidoff; Kerin B Adelson; Carolyn J Presley; Blythe J Adamson; Pooja Shaw; Ravi B Parikh; Ronac Mamtani; Cary P Gross
Journal:  JCO Oncol Pract       Date:  2020-07-17

2.  Developing and Sustaining an Effective and Resilient Oncology Careforce: Opportunities for Action.

Authors:  Samuel U Takvorian; Erin Balogh; Sharyl Nass; Virginia L Valentin; Lori Hoffman-Hogg; Randall A Oyer; Robert W Carlson; Neal J Meropol; Lisa Kennedy Sheldon; Lawrence N Shulman
Journal:  J Natl Cancer Inst       Date:  2020-07-01       Impact factor: 13.506
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.